CASTLE BIOSCIENCES, INC. Debt Instrument, Fair Value Disclosure
CASTLE BIOSCIENCES, INC. (CSTL) had Debt Instrument, Fair Value Disclosure of $10.07 million as of 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Notes › Debt › Debt Instruments
us-gaap:DebtInstrumentFairValue · last filed 2026-07-30
- 2026-06-30: Debt Instrument, Fair Value Disclosure $10.07M.
- 2026-03-31: Debt Instrument, Fair Value Disclosure $10.07M.
- 2025-12-31: Debt Instrument, Fair Value Disclosure $10.06M.
| Period end | Debt Instrument, Fair Value Disclosure |
|---|---|
| 2026-06-30 | $10.07M 10-Q · filed 2026-07-30 |
| 2026-03-31 | $10.07M 10-Q · filed 2026-05-06 |
| 2025-12-31 | $10.06M 10-Q · filed 2026-07-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Advanced Biomed Inc. (ADVB) | $0.009B |